Revascularization in heart failure: coronary bypass or percutaneous coronary intervention?
Coronary artery disease (CAD) is the most common cause of heart failure in Western countries. Selected patients who have low left ventricular ejection fraction (LVEF) and CAD clearly benefit from coronary revascularization with coronary artery bypass grafting (CABG). CABG results seem to be superior to percutaneous coronary intervention (PCI) in the few comparative studies of the two approaches in patients who have CAD and low LVEF completed to date. Clinical improvement should be expected in most patients who undergo CABG. This is important for patients who have a limited life span that they could spend with a good functional status rather than being hospitalized for multiple repeat PCIs or symptomatic deterioration.
Pusca
Sorin V
SV
Emory University School of Medicine, Atlanta, GA 30308, USA.
Puskas
John D
JD
D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D008297:Male; D009204:Myocardial Revascularization / Q000379:methods*; D018579:Patient Selection; D016016:Proportional Hazards Models; D012307:Risk Factors; D013318:Stroke Volume; D016896:Treatment Outcome